In contrast, a recent study reported up to 34% of meningiomas to be positive for S100; however, in this study, tumors were rated as S100 positive when at least 5% of tumor cells expressed S100 (Boulagnon-Rombi et al. 2017). This evidence concerns the gene S100B and meningioma.